Evidence map›Paper›PMID 31827407›Full record

ArticleJournal of inflammation (London, England)2019

Nrdp1 increases neuron apoptosis via downregulation of Bruce following intracerebral haemorrhage.

Changlong Zhou, Qingjun Liu, Wang Zhao, Ling Yang, Zhongyan Huang, Zhao Yang

Open access · goldAbstract read
In one paragraph

Article in Journal of inflammation (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Changlong Zhou1Department of Neurosurgery, Yongchuan Hospital, Chongqing Medical University, Chongqing, 402160 China.
Qingjun Liu2Department of Neurology, Yongchuan Hospital, Chongqing Medical University, Chongqing, 402160 China.
Wang Zhao2Department of Neurology, Yongchuan Hospital, Chongqing Medical University, Chongqing, 402160 China.
Ling Yang2Department of Neurology, Yongchuan Hospital, Chongqing Medical University, Chongqing, 402160 China.
Zhongyan Huang2Department of Neurology, Yongchuan Hospital, Chongqing Medical University, Chongqing, 402160 China.
Zhao Yang2Department of Neurology, Yongchuan Hospital, Chongqing Medical University, Chongqing, 402160 China.
Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeuregulin receptor degradation protein-1 (Nrdp1) is an E3 ubiquitin ligase that plays an important role in regulating cell growth, apoptosis and oxidative stress. However, the data regarding its expression and exact mechanism in neuronal injury following ICH has not been well identified.

methodsIn this study, primary cortical neurons from C57BL/6 mice were subjected to erythrocyte lysates. Nrdp1 expression, cell apoptosis, caspase-3 and BRUCE levels were detected. In addition, inflammatory response, brain edema, and neurological injury in ICH mice were also assessed.

resultsWe found that the expression of Nrdp1 was significantly increased in neuron cells accompanied by up-regulation of active caspase-3 and decreased expression of BRUCE (an inhibitor of apoptosis protein). However, inhibiting Nrdp1 levels of neurons reduced caspase-3 activity but induced up-regulation of BRUCE. In vivo, inhibiting Nrdp1 levels increased pro-inflammatory cytokines, brain edema, and neurological injury following ICH.

conclusionsTaken together, the data suggested that Nrdp1 might play a crucial role in neuronal apoptosis via inhibiting BRUCE following ICH.

Indexed as

ApoptosisBruceICHNeuronNrdp1

Identifiers

PMID31827407
PMCPMC6902554
OpenAlexW2993646027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.